3rd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions

LobbyistCovered position, as disclosed
STACEY FAHRNER VP Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 605 (112th)

Health Issues HCR

HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions

LobbyistCovered position, as disclosed
STACEY FAHRNER VP Government Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1058 (112th), H.R. 1971 (112th), H.R. 1946 (112th), H.R. 605 (112th)

Pharmacy PHA

HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform

LobbyistCovered position, as disclosed
STACEY FAHRNER VP Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1946 (112th), H.R. 1971 (112th), S. 1058 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.